Biostar Pharmaceuticals (BSPM) News Today → The system that called 2023’s top 7 stocks is at it again… (From WealthPress) (Ad) Free BSPM Stock Alerts Add Compare Share Share HeadlinesStock AnalysisChartStock AnalysisChart All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineBiostar Pharma Announces First Patient Enrolled for Phase 1 Study of Utidelone Capsule (UTD2)--The World's First Oral Epothilone Anti-Cancer Drugbenzinga.com - June 12 at 5:00 PMBioCryst Pharmaceuticals Stock Down 20% After Wider 4Q Loss Reportedmarketwatch.com - February 23 at 4:40 PMBiostar Pharmaceuticals, Inc. (BSPM)finance.yahoo.com - August 14 at 9:09 PMBiostar launches new mining rig with 8 graphics cardsmsn.com - April 28 at 9:52 AMHow an Uplisting Worksthestreet.com - February 21 at 12:58 AMBiostar: Best Small-Cap Pharma Stockthestreet.com - January 26 at 7:40 PMBiostar Pharmaceuticals Inc.barrons.com - August 27 at 8:36 PMBiostar Z590I Valkyrie Motherboardmsn.com - August 25 at 6:56 AM Get Biostar Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for BSPM and its competitors with MarketBeat's FREE daily newsletter. Email Address Putin and other countries have a plan (Ad)Did you catch that bombshell Tucker Carlson interview with Vladimir Putin? It’s not about if you like Tucker or think Putin is the devil or whatever. It's all about the fact that the US dollar might be taking a back seat... and soon. Click to kickstart your journey to survive in the new economy BSPM Media Mentions By Week BSPM Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BSPM News Sentiment▼0.000.46▲Average Medical News Sentiment BSPM News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BSPM Articles This Week▼00▲BSPM Articles Average Week Get Biostar Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for BSPM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Bayer Aktiengesellschaft News Context Therapeutics News EOM Pharmaceuticals News Genmab A/S News Grifols News Hypera News IMV News International Stem Cell News LAVA Therapeutics News Mainz Biomed News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:BSPM) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill Publishingtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biostar Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
